HIV - The Aurum Institute

Advancements in HIV Prevention: A Conversation with Dr. Kathryn Mngadi

As Sexual Transmitted Infections (STI) and Condom Week unfolds, it's imperative to reflect on the remarkable progress in HIV prevention over the years. Dr. Kathryn Mngadi, an esteemed figure with over...
Peer support after prison improves linkage to HIV care, South African study shows

...
From Idea to Impact: The Pelebox Innovator Earns Recognition

As The Aurum Institute we celebrate Neo Hutiri, the innovative mind behind Pelebox, a revolutionary smart locker system transforming healthcare access. Neo's invention has drastically reduced wait tim...
Prof Kaleebu receives the honorary title of Officer of the Most Excellent Order of the British Empire

Professor Pontiano Kaleebu, an esteemed Aurum Board Member and the outgoing Director of the Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicin...
Gilead Announces 100% Efficacy in HIV Prevention for Cisgender Women with Lenacapavir in Aurum conducted trial

The Aurum Institute welcomes the announcement from Gilead on the provisional results of the Phase 3 PURPOSE 1 trial. The trial has demonstrated that Gilead's twice-yearly injectable HIV-1 capsid inhib...
IIMPAACT4HIV: transforming advanced HIV disease (AHD) care

We are excited to announce the launch of IMPAACT4HIV, a Unitaid-funded project dedicated to transforming advanced HIV disease (AHD) care. Our goal is to significantly reduce AIDS-related mortality by ...
HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study

Lindquist, L., Kilembe, W., Karita, E., Price, M.A., Kamali, A., Kaleebu, P., Tang, J., Allen, S., Hunter, E., Gilmour, J. and Rowland-Jones, S.L., 2024, April. HLA-A* 23 Is Associated With Lower Odds...
Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, p

Borges, Á.H. et al. (2025) ‘Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV‐negative adults successfully treated for dr...
Corrigendum: The evolution of HIV self-testing and the introduction of digital interventions to improve HIV self-testing.

Fischer, A.E., Abrahams, M., Shankland, L., Lalla-Edward, S.T., Edward, V.A. and De Wit, J., 2023. The evolution of HIV self-testing and the introduction of digital interventions to improve HIV self-t...
PEPFAR held 'hostage' by partisan politics as experts warn of losing decades of progress

...
Webinar: Smart Integration: Advancing Person-Centered Care in the HIV Response

...
Advancing Person-Centered Care in the HIV Response

Integration is essential for sustaining progress in the HIV response, ensuring high-quality, accessible services while building towards long-term health system sustainability. The webinar Smart Integr...
US Senate Representative Applauds Efforts to Support Key Populations in Tshwane

...
Aurum's OP Team Showcases Best Practices at PHASA 2025

The annual Public Health Association of South Africa (PHASA) Conference took place from 6–9 April in Worcester, convening public health professionals from across South Africa, the continent, and bey...
World AIDS Day 2024: A Journey of Resilience, Hope, and Advocacy

Thandi Shabangu’s story is one of resilience, transformation, and unwavering commitment to helping others. A member of the Community Advisory Board at The Aurum Institute, Thandi has dedicated much ...

Advancements in HIV Prevention: A Conversation with Dr. Kathryn Mngadi

Peer support after prison improves linkage to HIV care, South African study shows

From Idea to Impact: The Pelebox Innovator Earns Recognition

Prof Kaleebu receives the honorary title of Officer of the Most Excellent Order of the British Empire

Gilead Announces 100% Efficacy in HIV Prevention for Cisgender Women with Lenacapavir in Aurum conducted trial

IIMPAACT4HIV: transforming advanced HIV disease (AHD) care

HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, p

Corrigendum: The evolution of HIV self-testing and the introduction of digital interventions to improve HIV self-testing.

PEPFAR held 'hostage' by partisan politics as experts warn of losing decades of progress

Webinar: Smart Integration: Advancing Person-Centered Care in the HIV Response

Advancing Person-Centered Care in the HIV Response

US Senate Representative Applauds Efforts to Support Key Populations in Tshwane

Aurum's OP Team Showcases Best Practices at PHASA 2025

World AIDS Day 2024: A Journey of Resilience, Hope, and Advocacy

Popular Tags

Most Read

Recent Posts